Apontis Pharma AG

DB:APPH Stock Report

Market Cap: €80.3m

Apontis Pharma Future Growth

Future criteria checks 4/6

Apontis Pharma is forecast to grow earnings and revenue by 78.1% and 17.3% per annum respectively. EPS is expected to grow by 78.3% per annum. Return on equity is forecast to be 18.3% in 3 years.

Key information

78.1%

Earnings growth rate

78.3%

EPS growth rate

Pharmaceuticals earnings growth21.6%
Revenue growth rate17.3%
Future return on equity18.3%
Analyst coverage

Low

Last updated19 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:APPH - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266866104
12/31/2025573064
12/31/2024491-10-72
6/30/202441-7-10-7N/A
3/31/202439-9-13-10N/A
12/31/202337-11-16-13N/A
9/30/202342-7-11-8N/A
6/30/202346-3-6-3N/A
3/31/202351014N/A
12/31/2022563811N/A
9/30/202256358N/A
6/30/202256436N/A
3/31/202254225N/A
12/31/202151-123N/A
9/30/202148-145N/A
6/30/202146-166N/A
3/31/202142-134N/A
12/31/202039-111N/A
12/31/201940-2-10N/A
12/31/201820001N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: APPH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: APPH is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: APPH is expected to become profitable in the next 3 years.

Revenue vs Market: APPH's revenue (17.3% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: APPH's revenue (17.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: APPH's Return on Equity is forecast to be low in 3 years time (18.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y